Sudha N. Rao, Ph.D. has over two decades of experience as a Researcher and Entrepreneur, having co-founded India's pioneering genomics company, Genotypic Technology Pvt Ltd. in 1998. She earned her Ph.D. in Biotechnology from Madurai Kamaraj University in 1996 followed by post-doctoral studies in Neurobiology at Cornell Medical School, New York. She has engaged in several credit-worthy collaborative research programs in genomics resulting in several publications under her authorship. She has been awarded Research Grants for work in Technology development for Diagnostics of Rare disorders and is on the Board of studies of several reputed Institutions including PSGTECH Coimbatore.

Awards & Recognitions:
1. Smt. Chandaben Mohanbhai Patel VASVIK Award for Women Scientific (Chemical Science &Technology) – 2019
2. Director on the Karnataka -Board of directors- Bangalore Bioinnovation Centre

Kannan Ramesh has over 25 years of consulting experience in Management, Business, Finance and Strategy with a specialisation in Healthcare Consulting. He has helped several respected names in the healthcare industry to scale-up across multiple areas and geographies.

Some of the healthcare brands with whom he has had a long engagement with includes Sahyadri Hospitals, Vikram Hospitals, Image Hospitals HCG ( BIO & Curie ), Indus Health Plus, Jhankaria Imaging ( now SRL), Mallya Hospital, GVN Hospitals, Express Clinics, NU Hospitals, Kosmoderma, VS Hospitals, Sparsh Nephrocare, Cygnus Hospitals, etc.

Prof. Samir K. Brahmachari is the pioneer of functional genomics in India. He was the Founder-Director of Institute of Genomics and Integrative Biology, New Delhi, prior to which he was a Professor in Molecular Biophysics Unit, Indian Institute of Science, Bangalore.

Prof Brahmachari made fundamental contributions in elucidating the role of repetitive DNA in genome function using a trans-disciplinary approach, integrating structural biology with genomics, molecular biology and information science. He successfully led the well-recognized Indian Genome Variation Project towards establishing the human genome variation in multi ethnic, multilingual populations of India as a national resource. Prof Brahmachari mentors Dhiti Omics team in its pursuit to develop affordable and actionable diagnostics by utilizing genomics and computational biology tools.

Meena comes with over 20 years of experience in various domains across technology, business strategy and marketing, having worked in global leadership roles with a number of blue-chip firms across the pharmaceutical and technology industries, like Monsanto, Honeywell, and HCL. She is a social entrepreneur, having set up niiti consulting



(www.niiticonsulting.com) in 2010 to provide strategy and research support to the social sector. She specialises in conceptualising and implementing new initiatives, and has a number of rewards and recognitions under her belt.

Meena has a double Masters' in Biotechnology and Management, a certificate in Social Entrepreneurship from INSEAD and teaches management and entrepreneurship as guest faculty at several Universities in India and abroad.

Dr. Anand has a unique knowledge base, skills and professional experience for over 17 years as a clinician, pathologist and molecular level research scientist both in academia and industry, in USA and India. He completed his M.B.B.S, medical degree from Madras Medical College, Chennai and later completed M.D. in Pathology with a gold medal and honours. He completed training in molecular biology and immunology at premier Institutes in India including All India Institute of Medical Sciences and pursued his postdoctoral research fellowship at Fred Hutchinson Cancer Research Centre, Seattle, USA. His research focused on the immunogenetics of bone marrow transplantation in leukemia patients to identify new genetic markers that can reduce Graft versus Host Disease and increase patient survival. He served as Research Director at Genotypic Technology Pvt Ltd, a leading genomics company in India and worked on many external and internal R &D projects, securing Indo-US research grants, collaborations and worked towards various research & clinical applications of genomics including methodologies like DNA Microarrays, Next Generation Sequencing, Exome sequencing etc.

Dr. Anand's passion has been in correlating clinical, pathological and genetic/ molecular data and bridging the lacunae on each side towards accurate interpretation of novel molecular diagnostic tests and delivering high quality reports for the clinics in the era of personalised/ precision medicine. He has several Original research articles, book chapters, case reports and paper presentations and awards at the International and National level to his credit. He is currently a practising pathologist and Consultant in Molecular Diagnostics & Molecular Pathology with ongoing research in molecular oncology